首页> 外文会议>Latin American Congress on Biomedical Engineering >Osteoblasts Derived from Autologous Human Stem Cells to Graft Jawbone Deficiencies
【24h】

Osteoblasts Derived from Autologous Human Stem Cells to Graft Jawbone Deficiencies

机译:从自体人干细胞中衍生的成骨细胞以移植颚骨缺陷

获取原文

摘要

Grafting of jaw bone deficiencies is a key step prior to dental rehabilitation and functional restoration. Autologously harvested bone grafts are considered to be the best graft material. The presence of vital cells and its nature makes autologous bone grafts, especially from the iliac crest, an excellent choice over other materials. Unfortunately, the necessity of a second surgical site (donor area) with its accompanying morbidity and post-operative complications often negate the benefits. Human mesenchymal stem cells obtained from bone marrow of the posterior iliac crest in a minimally invasive procedure are used to culture osteoblasts which are then placed in a gel formulation in the deficient areas. This procedure fulfills all the advantages of an autologous bone graft without any of the attendant problems of the surgery and undesirable post-operative sequelae. Clinical treatment cases arc shown to highlight the advantage of this treatment modality.
机译:颌骨缺陷的嫁接是牙科康复和功能恢复之前的关键步骤。自动收获的骨移植物被认为是最好的接枝材料。重要细胞的存在及其性质使自体骨移植物,尤其是髂嵴,对其他材料的出色选择。不幸的是,第二个外科部位(供体区)的必要性具有伴随的发病率和术后并发症往往会否定益处。在微创手术中从后髂嵴的骨髓获得的人间充质干细胞用于培养骨细胞,然后将其置于缺乏区域中的凝胶制剂中。该程序满足了自体骨移植的所有优点,而无需手术和不期望的后术后后遗症的任何伴随问题。临床治疗病例弧显示为突出这种治疗方式的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号